Breaking News
November 15, 2018 - Researchers develop tool that speeds up analysis and publication of biomedical data
November 15, 2018 - Scientists identify mechanism used by lung cancer cells to obtain glucose
November 15, 2018 - Abnormalities in development of the brain could be involved in onset of autism, finds new study
November 15, 2018 - Soy protein equally effective as animal protein in building muscle strength
November 15, 2018 - American Academy of Pediatrics, Nov. 2-6
November 15, 2018 - Dopamine drives early addiction to heroin
November 15, 2018 - Variance in gut microbiome in Himalayan populations linked to dietary lifestyle | News Center
November 15, 2018 - Reducing Cardiovascular Disease: The Amish Way
November 15, 2018 - King’s researchers launch charter to guide organizations to engage abuse survivors in research
November 15, 2018 - Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals
November 15, 2018 - TGen North collaborates with NARBHA Institute to advance human health
November 15, 2018 - Researchers discover molecular basis for therapeutic actions of an African folk medicine
November 15, 2018 - Human Cell Atlas study of early pregnancy shows how mother’s immune system is modified
November 15, 2018 - New guidelines for detecting and managing sarcopenia to be launched in the UK
November 15, 2018 - Researchers explore role of dietary composition on energy expenditure
November 15, 2018 - Elsevier launches Entellect™ Platform, unlocking value by creating AI-ready life sciences data
November 15, 2018 - Now that cannabis is legal in Canada, let’s use it to tackle the opioid crisis
November 15, 2018 - In the Spotlight: At the intersection of tech, health, and ethics
November 15, 2018 - Traditional Glaucoma Test Can Miss Severity of the Disease
November 15, 2018 - Researchers directly connect activities of genes with instinctive behavior in male cichlids
November 15, 2018 - Salk researchers report new methods to identify AD drug candidates with anti-aging properties
November 15, 2018 - St. Jude Hospital announces availability of largest collections of leukemia samples
November 15, 2018 - Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline
November 15, 2018 - Designing a novel cell-permeable peptide chimera to promote wound healing
November 15, 2018 - NEI investigators combine two imaging modalities to view the retina in unprecedented detail
November 15, 2018 - Determining how hearts develop to better understand congenital heart defects
November 15, 2018 - Maverick immune cells can act independently to identify and kill cancer cells, finds research
November 15, 2018 - Advanced AI and big data methods to tackle dementia
November 15, 2018 - Report reveals increase in pancreatic cancer death rates across Europe
November 15, 2018 - Luxia Scientific announces availability of its gut microbiome test in Luxembourg
November 15, 2018 - New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis
November 15, 2018 - Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine
November 15, 2018 - Heart failure patients shouldn’t stop meds even if condition improves: study
November 15, 2018 - RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders
November 15, 2018 - Breakthrough research could lead to a new wave of cancer-fighting antibodies
November 15, 2018 - Mylan and Biocon launch new insulin glargine biosimilar in the UK
November 15, 2018 - For wildfire safety, only particular masks guard against toxic particulate matter
November 15, 2018 - New study of tribe shows influence of Western diet and lifestyle on blood pressure
November 15, 2018 - Scientists harness power of natural killer cells to treat children with neuroblastoma
November 15, 2018 - Investigating foodborne disease outbreak in Bosnia and Herzegovina based on simulation game
November 15, 2018 - Recommendations Issued for Management of Bradycardia
November 15, 2018 - Benefit unclear due to a lack of suitable studies
November 15, 2018 - TAMEST recognizes UT Southwestern’s Ralph DeBerardinis for changing our understanding of cancer
November 15, 2018 - Researchers discover key factors behind intestinal inflammation in CVID patients
November 15, 2018 - CityU develops first microarrayed 3D neuronal culture platform
November 15, 2018 - Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women
November 15, 2018 - New edition of Red Journal focuses on roles of imaging in radiation oncology
November 15, 2018 - Doctors Aren’t Promoting Breastfeeding’s Cancer-Protection Benefit
November 15, 2018 - Collection of demonstration projects highlights value of patient engagement in research
November 15, 2018 - Technique to ‘listen’ to a patient’s brain during tumour surgery
November 15, 2018 - Seven-year-old returns to life as a “normal, healthy child” following bone marrow transplant
November 15, 2018 - AMSBIO expands range of high quality FFPE cancer cell line controls
November 15, 2018 - Marijuana use by kidney donors has no effect on transplant outcomes
November 15, 2018 - Exploring NMR Spectroscopy Applications through Interesting Infographics
November 15, 2018 - Chapman University wins additional $2.9 million NIH grant to study Alzheimer’s disease
November 15, 2018 - Microgel powder reduces infection and promotes healing
November 15, 2018 - Suicidal patients with prescribed access to psychotropic drugs should be closely monitored
November 15, 2018 - Nitric oxide-releasing technology shows potential to reduce healing time of diabetic foot ulcers
November 15, 2018 - Mass shootings may trigger unnecessary blood donations
November 15, 2018 - From heart disease to cancer: New study tracks shift of county death rates
November 15, 2018 - Preventing falls with new sensor technology
November 15, 2018 - Promising technology could improve detection, diagnosis of fatal ovarian cancer
November 15, 2018 - AAP updates concussion recommendations for children and teens
November 15, 2018 - Two genomic tests help identify most effective treatment for breast cancer patients
November 15, 2018 - Researchers evaluate efficacy of salivary biomarkers for early detection of oral cancer
November 15, 2018 - NIH awards $3.5 million to continue development of robotic system for treating brain tumors
November 15, 2018 - Researchers succeed in building protein nanotubes from tiny scaffolds
November 15, 2018 - Rectal bleeding
November 15, 2018 - Nasal delivery of weight-loss hormone eases breathing problems in sleeping mice
November 15, 2018 - $9.6 million grant to fund research on vascular risk factors for brain aging, dementia | News Center
November 15, 2018 - Gum disease linked with diabetes
November 15, 2018 - Study identifies unique functional brain networks associated with ASD behaviors in infancy
November 15, 2018 - EU and industry-funded project aims to personalize diabetes treatment
November 15, 2018 - NIH researchers shed light on causes of HBV-associated acute liver failure
November 14, 2018 - FDA Alert: Implanted Pumps: Safety Communication
November 14, 2018 - Weight loss & acute Porphyria
November 14, 2018 - Researchers identify three sub-types of depression
November 14, 2018 - The puzzle of a mutated gene lurking behind many Parkinson’s cases | News Center
November 14, 2018 - The mystery viruses far worse than flu
November 14, 2018 - Research highlights physical changes in the brain of self-injuring teen girls
5 Questions: What parents should know about poliolike illness | News Center

5 Questions: What parents should know about poliolike illness | News Center

image_pdfDownload PDFimage_print

Recently, cases of a poliolike illness have been back in the news. Acute flaccid myelitis, a rare complication from certain viral infections, causes paralysis in one or more limbs and strikes mostly children. Keith Van Haren, MD, assistant professor of neurology and neurological sciences at the School of Medicine, has studied the condition and written scientific review articles covering clusters of cases dating back to 2012.

Van Haren talked with science writer Erin Digitale about what parents should know about the disease.

Q: What do we know about the history and causes of this condition?

Van Haren: There are cases of infectious paralysis stretching far back into recorded human history, including, of course, of poliomyelitis. The best interpretation of current and historical evidence suggests these cases are primarily caused by viral infections, and there happen to be several viruses that can do this. Broadly speaking, we could classify poliomyelitis as a form of acute flaccid myelitis; they appear to share similar elements of pathophysiology.

Enteroviruses — including the three human polioviruses, and enterovirus 71 — are the most common culprits. Since at least 2012, there is accumulating evidence that enterovirus 68 can also cause this syndrome. And West Nile Virus can cause this acute flaccid myelitis, although it’s from a different family of viruses.

As best we can tell, the modern outbreaks go back to at least 2012, when Carol Glaser and her team at the California Department of Public Health began noticing an uptick in poliolike cases, mostly in kids. It was Carol who first noticed the viral association with enterovirus 68. 

The phrase “acute flaccid myelitis” was coined in 2014 by a group of colleagues, including myself, who were trying to come up with an appropriate descriptive term that would disentangle it from the historical association with poliomyelitis and provide a broader framework for characterizing the illness.

The pattern that we’re currently seeing is an every-other-year phenomenon. Different years bring different enteroviruses, just as different years bring different strains of flu. In the years enterovirus 68 has been circulating — in 2012, 2014, 2016 and 2018 — we’ve also seen an increase in cases all clustered in late summer and early fall, which is the time of year that many species of enteroviruses circulate in North America. 

Q: What happens in children affected with acute flaccid myelitis?

Van Haren: The syndrome typically begins with what looks like a traditional systemic illness. This is broadly true of many infectious neurological illnesses: What begins as an otherwise ordinary infection takes a different course in a particular patient, and it’s not understood why.

Enterovirus infections typically start and end as benign illnesses, with congestion, fever and a sense of malaise all lasting a few days. In a very small number of individuals, this illness is followed by something more ominous. The earliest symptom among patients who actually develop acute flaccid myelitis is a period of significant pain in the limb, or multiple limbs, often described as aching, tingling or electric shocks. Within the next day or so, the limb becomes weak and the weakness can progress very quickly, over the course of an hour or two even, to very weak or complete loss of function. Muscles of the face can also be affected.

The weakness may worsen for the next day or for several days before it reaches its low point and stabilizes. In many cases, the weakened limb does gradually recover, though it may not make a full recovery. Most recovery occurs in the first few months, but recovery may continue for years. We have seen apparent improvement continuing, albeit slowly, even as far out as two years after the injury.

Rehabilitation is sometimes possible once the illness is stabilized. Most rehabilitation efforts are taken on a case-by-case basis, and often include strength training and electrical stimulation devices that deliver tiny electrical pulses, applied directly over the muscle. There are also surgical approaches, in which a nerve that is not working is swapped for a nerve that is working to re-attain some muscle movement, typically in an arm, but it is not appropriate for everyone and is attempted only in very highly specialized centers. It requires a highly skilled team to identify who might benefit and plan the procedure.

Q: How worried should parents be? Is there anything they can or should do to protect their children?

Van Haren: With any infectious illness, the youngest and oldest members of population are most vulnerable. This condition is a bit of an exception, as it is primarily affecting younger children. 

To date, the best we can offer is a preventive approach: Try to help keep children healthy and clean with regular hand-washing and limited exposure to very sick people.

If a child is sick, parents should encourage him or her to rest and provide normal, appropriate nourishment and hydration. If the child or parent is noticing acute weakness or significant pain in one limb, they should seek medical care promptly.

It’s important to remember how rare this disease is. To put it in context, last year there were about 80,000 deaths across the country from the flu; so far this year, there are around 100 or so total cases of acute flaccid myelitis under investigation. Clinicians and scientists are working hard to understand how to make sure it doesn’t become more and, ideally, to eliminate it altogether. Analogous eradication efforts have occurred many times, primarily through vaccination. 

Q: What are experts doing to better understand the illness?

Van Haren: The physician community, including child neurologists and infectious disease specialists, is coming together to form working groups to tackle the problem directly. Our general sense now is that this is a serious illness for anyone who is affected, but it remains rare.

Our goal is to understand what’s happening well enough to prevent it from becoming more common, and also to develop better modes to treat it. The physician community is seeing a convergence of evidence that suggests enterovirus 68 is responsible for many but not all cases. This community would like more support from public health agencies and funders to try to understand this disease.

Q: What do we know now about the illness that we didn’t know last time there were a significant number of cases?

Van Haren: There has been some really helpful progress in past couple of years in terms of modeling around enterovirus 68, focusing on the biology of the virus. Scientists have studied the genetic alterations that may have made the virus more prone to attack the human nervous system, and have tested the ability of the virus to do this in a mouse model. This is a crucial foundation for developing treatments and vaccinations. 

It’s somewhat disappointing that we don’t yet have a good therapeutic or really specific preventive approach. Those are the areas we ought to be making ardent strides toward.

Tagged with:

About author

Related Articles